Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
General Surgical Innovations (GSI) was a pioneering medical technology company that specialized in balloon-based tissue dissection and access systems for minimally invasive surgery. Founded in 1992 by the renowned surgeon and inventor Dr. Thomas Fogarty, the company developed proprietary technology that used inflatable balloons to create operative space and visualize anatomy through small incisions. Its flagship products, including the Spacemaker and VasoView systems, revolutionized procedures such as laparoscopic hernia repair and endoscopic saphenous vein harvesting for bypass surgery. GSI successfully addressed the challenge of creating a working cavity in non-hollow anatomical areas, significantly reducing patient trauma and recovery times. The company was acquired by Tyco International in 1999 and its technologies are now part of the Medtronic surgical portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on General Surgical Innovations.